Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-99,984
Closed -$2.99M 2554
2025
Q3
$2.99M Sell
99,984
-48,784
-33% -$1.63M 0.02% 833
2025
Q2
$4.42M Buy
148,768
+4,725
+3% +$136K 0.03% 604
2025
Q1
$4.4M Buy
144,043
+77,394
+116% +$2.61M 0.03% 571
2024
Q4
$2.64M Buy
+66,649
New +$2.59M 0.02% 726
2019
Q1
Sell
-4,856
Closed -$230K 1247
2018
Q4
$230K Buy
+4,856
New +$291K 0.01% 904

Other funds holding SRDX

Steve Schonfeld's SRDX Position: Q4 2025 in Review

Steve Schonfeld sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 99,984 shares — an estimated $2.99M sold.

Steve Schonfeld first reported a position in SRDX in Q4 2018 and held it in 5 quarters. The position peaked at $4.42M in Q2 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Steve Schonfeld reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Steve Schonfeld sold 99,984 Surmodics shares in Q4 2025, an estimated $2.99M.
  • Steve Schonfeld first reported a position in Surmodics in Q4 2018 and held it in 5 quarters.
  • Steve Schonfeld's Surmodics position peaked at $4.42M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.